Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FKBP1A | P62942 | 11/20 | 0.55 |
| ▸ | ACE | P12821 | 7/20 | 0.53 |
| ▸ | DPP4 | P27487 | 1/20 | 0.52 |
| ▸ | DPP8 | Q6V1X1 | 1/20 | 0.52 |
| ▸ | DPP9 | Q86TI2 | 1/20 | 0.52 |
| ▸ | DPP7 | Q9UHL4 | 1/20 | 0.52 |
| ▸ | LMNA | P02545 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL38652340 | 0.89 | FKBP1A (0.53) | FKBP1AACEDPP4DPP8DPP9 | |
| SCHEMBL38652282 | 0.89 | FKBP1A (0.53) | FKBP1AACEDPP4DPP8DPP9 | |
| SCHEMBL8365666 | 0.89 | DPP4 (0.61) | FKBP1AACEDPP4DPP8DPP9 | |
| SCHEMBL7508784 | 0.89 | DPP4 (0.61) | FKBP1AACEDPP4DPP8DPP9 | |
| Hydrochloric Acid SCHEMBL38652210 | 0.88 | FKBP1A (0.53) | FKBP1AACEDPP4DPP8DPP9 | |
| SCHEMBL24645570 | 0.88 | ACE (0.56) | FKBP1AACELMNA | |
| Hydrochloric Acid SCHEMBL10403931 | 0.88 | DPP4 (0.60) | FKBP1AACEDPP4DPP8DPP9 | |
| SCHEMBL29290357 | 0.88 | FKBP1A (0.56) | FKBP1AACEDPP4DPP8DPP9 | |
| SCHEMBL10888137 | 0.87 | FKBP1A (0.54) | FKBP1AACEDPP4DPP8DPP9 | |
| Hydrochloric Acid SCHEMBL7327619 | 0.87 | FKBP1A (0.55) | FKBP1AACEDPP4DPP8DPP9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2003057722-A2 | CYCLIC TETRAPEPTIDE COMPOUND AND USE THEREOF | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2003-07-17 | — | — | WO | disclosed |